UNIT 1, Pharmacology RNSG 1301 EPCC: EXA
And Correct Answers
1. cA cnurse cis cassessing cthe cclient's chome cmedication cuse. cAfter clistening cto cthe cclient clist ccu
casks cwhat cpriority cquestion?
A) c"Do cyou ctake cany cgeneric cmedications?"
B) c"Are cany cof cthese cmedications corphan cdrugs?"
C) c"Are cthese cmedications csafe cto ctake cduring cpregnancy?"
D) c"Do cyou ctake cany cover-the-counter cmedications?" c- cCORRECT cANS✔✔D) c"Do cyou ctake ca
cmedications?"
2. cWhich cclassification capplies cto cMorphine?
A) ccentral cnervous csystem cdepressant
B) ccentral cnervous csystem cstimulant
C) canti-inflammatory
D) cantihypertensive c- cCORRECT cANS✔✔A) ccentral cnervous csystem cdepressant
3. cWhile cstudying cfor cthe ctest, ca cnursing cstudent cencounters cthe cfollowing cdrug: cibuprofen c(M
cstudent cidentify cthe cname cibuprofen cas?
A) cThe cgeneric cname
B) cThe cchemical cname
C) cThe cbrand cname
D) cThe cchemical cand cgeneric cname c- cCORRECT cANS✔✔A) cThe cgeneric cname
4. cA cnurse cis cteaching cthe cclient cabout cthe cuse cof cover cthe ccounter c(OTC) cdrugs. cWhich csta
cabout ctheir cuse?
A) c"OTC cdrugs care cproducts cthat care cavailable cwithout cprescription cfor cself-treatment cof cmino
B) c"OTC cdrugs care cconsidered cmedication cand cshould cbe creported con ca cdrug chistory."
C) c"OTC cdrugs cwere capproved cas cprescription cdrugs cbut clater cwere cfound cto cbe csafe cwithou
D) c"OTC cdrugs cneed cto cbe ctaken cwith ccaution; cthey ccan cmask cthe csigns cand csymptoms cof ca
,D) cThe cadministration cof cindividual cnarcotic cdoses care crecorded cin cspecific cunit cdocumentation
E) cAny crecognized cdiscrepancy cinvolving ca cnarcotic cmust cbe creported cto cthe cappropriate cfacil
7.Which corganization cis cresponsible cfor capproving cnew cdrugs cin cthe cUnited cStates?
A) cAmerican cMedical cAssociation c(AMA)
B) cAmerican cPharmaceutical cAssociation c(APA)
C) cFood cand cDrug cAdministration c(FDA)
D) cUnited cStates cPharmacopeia c- cCORRECT cANS✔✔C) cFood cand cDrug cAdministration c(FDA
8. cA cnursing cstudent cin ca cpharmacology cclass cshould cbe cencouraged cto cstudy cthe cmedication
ccategorization? cSelect call cthat capply.
A) cprototype
B) ccontrolled csubstance
C) cdrug cuse
D) cgeneric cnames
E) ctherapeutic cclassification c- cCORRECT cANS✔✔A) cprototype
E) ctherapeutic cclassification
9. cA cclient cis cconfused cand chas cstated cto cthe cnurse, c"I cwasn't csure cwhether cI'm csupposed cto
cacetaminophen." cTo cbest caddress cthe cclient's cconcern, cthe cnurse cshould cbase cthe cresponse
cconcerning cgeneric cand ctrade cnames?
A) cPrescribers cshould crefer csolely cto cgeneric cnames cin ctheir crecommendations cand cwritten cpr
B) cA cgeneric cname cis cindependent cof cany cparticular cdrug cmanufacturer.
C) cGeneric cnames cchange cfrequently, cbut ctrade cnames care cmore cconsistent.
D) cPrescribers cshould crefer csolely cto ctrade cnames cin ctheir crecommendations cand cwritten cpres
cANS✔✔B) cA cgeneric cname cis cindependent cof cany cparticular cdrug cmanufacturer.
10. cA cclient's ccurrent cmedication cadministration crecord cincludes ca cdrug cthat cthe cnurse crecogn
cMedication cPractices c(ISMP) chigh-alert cmedication. cThis cdesignation csignals cthe cnurse cto cwha
A) cIt ccan conly cbe cadministered cby ca chealth ccare cprovider cor cadvanced cpractice cnurse.
B) cAdministration cmust cbe ccosigned cby ca csecond cregistered cnurse cor cpractical/vocational cnurs
C) cIt cis ccurrently cundergoing cPhase c4 ctesting cand cis cpending cfull cFDA capproval.
D) cAdministration cerrors ccarry ca cheightened crisk cof ccausing csignificant cclient charm. c- cCORRE
cerrors ccarry ca cheightened crisk cof ccausing csignificant cclient charm.
11. cA chospital cnurse cis cvigilant cin censuring cthe csafe cuse cof cmedications cand cconsistently capp
cadministration. cWhat care cthe crights cof cmedication cadministration? cSelect call cthat capply.
A) cright cto crefuse cprescribed cmedication
B) cright croute cfor ceffective cmedication ctherapy
C) cright cto ceffective cmedication ceducation
D) cright cevaluation cof cexpected cresults
E) cright cto clow-cost cmedication ctherapy c- cCORRECT cANS✔✔A) cright cto crefuse cprescribed cme
B) cright croute cfor ceffective cmedication ctherapy
C) cright cto ceffective cmedication ceducation
D) cright cevaluation cof cexpected cresults
12. cThe cnurse cis ccaring cfor can colder cadult cwho cneeds cto cknow cthat cdrugs, ceven cwhen ctaken
cnegative cor cunexpected ceffects. cThe cnurse cshould caddress cwhat ctopic cduring chealth ceducatio
A) cTeratogenic ceffects
, 15. cAn colder cadult cclient chas can celevated cserum ccreatinine clevel. cThis cclient cis cat cgreatest cris
ceffect?
A) ctoxicity
B) cincreased cabsorption
C) cdelayed cgastric cemptying
D) cidiosyncratic ceffects c- cCORRECT cANS✔✔A) ctoxicity
16. cWhat cis cthe cprimary crole cof cprotein cbinding con cdrug caction?
A) cincreasing cthe cmedication's cspeed cof caction
B) cdecreasing cthe cmedication's cspeed cof caction
C) cincreasing cthe crate cof cthe cmedication's cexcretion
D) caverting cthe crisk cof cadverse ceffects cposed cby cthe cmedication c- cCORRECT cANS✔✔B) cdec
cspeed cof caction
17. cThe cnurse cis caware cthat cit crequires capproximately chow cmany chalf-lives cfor ca cclient cto cexc
cbody?
A) c4-5
B) c10-12
C) c20-25
D) c5-100 c- cCORRECT cANS✔✔A) c4-5
18. cWhich cstatement caccurately cdescribes cthe cconcept cof ca cmedication's cserum chalf-life?
A) cthe ctime crequired cfor cIV cmedications cto cpenetrate cthe cbrain ctissue
B) cthe ctime cneeded cfor cthe cserum clevel cto cfall cby c50%
C) cthe csafest cmargin cto cprevent ctoxicity
D) cthe cdose cadjustment cthat creduces cthe crisk cof cadverse ceffects cby cone chalf c- cCORRECT cA
cthe cserum clevel cto cfall cby c50%
19. cA cclient cpresents cto cthe cemergency cdepartment cwith ca cdrug clevel cof c50 cunit/mL. cThe chal
cWith cthis cdrug, cconcentrations cabove c25 cunits/mL care cconsidered ctoxic cand cnot cmore cdrug cis
cwill cit ctake cfor cthe cblood clevel cto creach cthe cnon-toxic crange?
A) c60
B) c30
C) c120
D) c30 c- cCORRECT cANS✔✔A) c60
20. cWhich cfactor caccounts cfor cthe cincreased crisk cfor cdrug creactions camong cclients caged c65 cy
A) cdrugs cmore creadily ccrossing cthe cblood-brain cbarrier cin colder cpeople
B) cphysiologic cchanges caffecting call cpharmacokinetic cprocesses
C) cincreased cdrug-metabolizing cenzymes cin colder cpeople
D) cdiminished cimmune cresponse c- cCORRECT cANS✔✔B) cphysiologic cchanges caffecting call cph
21. cA cclient chas cbeen cprescribed ca cmedication cthat cis cknown cto cbe ca cdrug cagonist. cThis cdru
A) cIt cwill creact cwith ca creceptor csite con ca ccell cpreventing ca creaction cwith canother cchemical con
B) cThe cdrug cwill cinterfere cwith cthe cenzyme csystem cthat cact cas ccatalyst cfor cdifferent cchemical
C) cThe cdrug cwill cinteract cdirectly cwith creceptor csites cto ccause cthe csame cactivity cthat ca cnatura
csite.
D) cIt cwill creact cwith creceptor csites cto cblock cnormal cstimulation, cproduction cno ceffect. c- cCORR
And Correct Answers
1. cA cnurse cis cassessing cthe cclient's chome cmedication cuse. cAfter clistening cto cthe cclient clist ccu
casks cwhat cpriority cquestion?
A) c"Do cyou ctake cany cgeneric cmedications?"
B) c"Are cany cof cthese cmedications corphan cdrugs?"
C) c"Are cthese cmedications csafe cto ctake cduring cpregnancy?"
D) c"Do cyou ctake cany cover-the-counter cmedications?" c- cCORRECT cANS✔✔D) c"Do cyou ctake ca
cmedications?"
2. cWhich cclassification capplies cto cMorphine?
A) ccentral cnervous csystem cdepressant
B) ccentral cnervous csystem cstimulant
C) canti-inflammatory
D) cantihypertensive c- cCORRECT cANS✔✔A) ccentral cnervous csystem cdepressant
3. cWhile cstudying cfor cthe ctest, ca cnursing cstudent cencounters cthe cfollowing cdrug: cibuprofen c(M
cstudent cidentify cthe cname cibuprofen cas?
A) cThe cgeneric cname
B) cThe cchemical cname
C) cThe cbrand cname
D) cThe cchemical cand cgeneric cname c- cCORRECT cANS✔✔A) cThe cgeneric cname
4. cA cnurse cis cteaching cthe cclient cabout cthe cuse cof cover cthe ccounter c(OTC) cdrugs. cWhich csta
cabout ctheir cuse?
A) c"OTC cdrugs care cproducts cthat care cavailable cwithout cprescription cfor cself-treatment cof cmino
B) c"OTC cdrugs care cconsidered cmedication cand cshould cbe creported con ca cdrug chistory."
C) c"OTC cdrugs cwere capproved cas cprescription cdrugs cbut clater cwere cfound cto cbe csafe cwithou
D) c"OTC cdrugs cneed cto cbe ctaken cwith ccaution; cthey ccan cmask cthe csigns cand csymptoms cof ca
,D) cThe cadministration cof cindividual cnarcotic cdoses care crecorded cin cspecific cunit cdocumentation
E) cAny crecognized cdiscrepancy cinvolving ca cnarcotic cmust cbe creported cto cthe cappropriate cfacil
7.Which corganization cis cresponsible cfor capproving cnew cdrugs cin cthe cUnited cStates?
A) cAmerican cMedical cAssociation c(AMA)
B) cAmerican cPharmaceutical cAssociation c(APA)
C) cFood cand cDrug cAdministration c(FDA)
D) cUnited cStates cPharmacopeia c- cCORRECT cANS✔✔C) cFood cand cDrug cAdministration c(FDA
8. cA cnursing cstudent cin ca cpharmacology cclass cshould cbe cencouraged cto cstudy cthe cmedication
ccategorization? cSelect call cthat capply.
A) cprototype
B) ccontrolled csubstance
C) cdrug cuse
D) cgeneric cnames
E) ctherapeutic cclassification c- cCORRECT cANS✔✔A) cprototype
E) ctherapeutic cclassification
9. cA cclient cis cconfused cand chas cstated cto cthe cnurse, c"I cwasn't csure cwhether cI'm csupposed cto
cacetaminophen." cTo cbest caddress cthe cclient's cconcern, cthe cnurse cshould cbase cthe cresponse
cconcerning cgeneric cand ctrade cnames?
A) cPrescribers cshould crefer csolely cto cgeneric cnames cin ctheir crecommendations cand cwritten cpr
B) cA cgeneric cname cis cindependent cof cany cparticular cdrug cmanufacturer.
C) cGeneric cnames cchange cfrequently, cbut ctrade cnames care cmore cconsistent.
D) cPrescribers cshould crefer csolely cto ctrade cnames cin ctheir crecommendations cand cwritten cpres
cANS✔✔B) cA cgeneric cname cis cindependent cof cany cparticular cdrug cmanufacturer.
10. cA cclient's ccurrent cmedication cadministration crecord cincludes ca cdrug cthat cthe cnurse crecogn
cMedication cPractices c(ISMP) chigh-alert cmedication. cThis cdesignation csignals cthe cnurse cto cwha
A) cIt ccan conly cbe cadministered cby ca chealth ccare cprovider cor cadvanced cpractice cnurse.
B) cAdministration cmust cbe ccosigned cby ca csecond cregistered cnurse cor cpractical/vocational cnurs
C) cIt cis ccurrently cundergoing cPhase c4 ctesting cand cis cpending cfull cFDA capproval.
D) cAdministration cerrors ccarry ca cheightened crisk cof ccausing csignificant cclient charm. c- cCORRE
cerrors ccarry ca cheightened crisk cof ccausing csignificant cclient charm.
11. cA chospital cnurse cis cvigilant cin censuring cthe csafe cuse cof cmedications cand cconsistently capp
cadministration. cWhat care cthe crights cof cmedication cadministration? cSelect call cthat capply.
A) cright cto crefuse cprescribed cmedication
B) cright croute cfor ceffective cmedication ctherapy
C) cright cto ceffective cmedication ceducation
D) cright cevaluation cof cexpected cresults
E) cright cto clow-cost cmedication ctherapy c- cCORRECT cANS✔✔A) cright cto crefuse cprescribed cme
B) cright croute cfor ceffective cmedication ctherapy
C) cright cto ceffective cmedication ceducation
D) cright cevaluation cof cexpected cresults
12. cThe cnurse cis ccaring cfor can colder cadult cwho cneeds cto cknow cthat cdrugs, ceven cwhen ctaken
cnegative cor cunexpected ceffects. cThe cnurse cshould caddress cwhat ctopic cduring chealth ceducatio
A) cTeratogenic ceffects
, 15. cAn colder cadult cclient chas can celevated cserum ccreatinine clevel. cThis cclient cis cat cgreatest cris
ceffect?
A) ctoxicity
B) cincreased cabsorption
C) cdelayed cgastric cemptying
D) cidiosyncratic ceffects c- cCORRECT cANS✔✔A) ctoxicity
16. cWhat cis cthe cprimary crole cof cprotein cbinding con cdrug caction?
A) cincreasing cthe cmedication's cspeed cof caction
B) cdecreasing cthe cmedication's cspeed cof caction
C) cincreasing cthe crate cof cthe cmedication's cexcretion
D) caverting cthe crisk cof cadverse ceffects cposed cby cthe cmedication c- cCORRECT cANS✔✔B) cdec
cspeed cof caction
17. cThe cnurse cis caware cthat cit crequires capproximately chow cmany chalf-lives cfor ca cclient cto cexc
cbody?
A) c4-5
B) c10-12
C) c20-25
D) c5-100 c- cCORRECT cANS✔✔A) c4-5
18. cWhich cstatement caccurately cdescribes cthe cconcept cof ca cmedication's cserum chalf-life?
A) cthe ctime crequired cfor cIV cmedications cto cpenetrate cthe cbrain ctissue
B) cthe ctime cneeded cfor cthe cserum clevel cto cfall cby c50%
C) cthe csafest cmargin cto cprevent ctoxicity
D) cthe cdose cadjustment cthat creduces cthe crisk cof cadverse ceffects cby cone chalf c- cCORRECT cA
cthe cserum clevel cto cfall cby c50%
19. cA cclient cpresents cto cthe cemergency cdepartment cwith ca cdrug clevel cof c50 cunit/mL. cThe chal
cWith cthis cdrug, cconcentrations cabove c25 cunits/mL care cconsidered ctoxic cand cnot cmore cdrug cis
cwill cit ctake cfor cthe cblood clevel cto creach cthe cnon-toxic crange?
A) c60
B) c30
C) c120
D) c30 c- cCORRECT cANS✔✔A) c60
20. cWhich cfactor caccounts cfor cthe cincreased crisk cfor cdrug creactions camong cclients caged c65 cy
A) cdrugs cmore creadily ccrossing cthe cblood-brain cbarrier cin colder cpeople
B) cphysiologic cchanges caffecting call cpharmacokinetic cprocesses
C) cincreased cdrug-metabolizing cenzymes cin colder cpeople
D) cdiminished cimmune cresponse c- cCORRECT cANS✔✔B) cphysiologic cchanges caffecting call cph
21. cA cclient chas cbeen cprescribed ca cmedication cthat cis cknown cto cbe ca cdrug cagonist. cThis cdru
A) cIt cwill creact cwith ca creceptor csite con ca ccell cpreventing ca creaction cwith canother cchemical con
B) cThe cdrug cwill cinterfere cwith cthe cenzyme csystem cthat cact cas ccatalyst cfor cdifferent cchemical
C) cThe cdrug cwill cinteract cdirectly cwith creceptor csites cto ccause cthe csame cactivity cthat ca cnatura
csite.
D) cIt cwill creact cwith creceptor csites cto cblock cnormal cstimulation, cproduction cno ceffect. c- cCORR
